Drug Interaction Study of ALXN2050 With Fluconazole and Rifampin in Healthy Adult Participants
Clinical trial NCT04933682 · COMPLETED
Trial details
- NCT number
- NCT04933682
- Sponsor
- Alexion Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-06-07
- Primary completion
- 2021-08-23
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.